Plunkett Research Online: Biocure Technology

BIOCURE TECHNOLOGY (CURE:CNQ) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Biocure Technology Inc is a South Korean based Bio Pharmaceutical company specializing in the development and potential commercialization of biosimilar pharmaceutical products. It is in the process of preclinical trials of five major biosimilar products in South Korea, including Interferon Beta 1b, .....



Biocure Technology
Ticker: CURE
Exchange: CNQ
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 604 630-3838
Fax: 888 241-5996
Address: 1055 West Hastings Street
Suite 300
Vancouver, BC V6E 2E9 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
Contacts Description
Ruben Verzosa CEO/Director/President
Nizar Bharmal CFO/Director
See More
Biocure Technology Inc is a South Korean based Bio Pharmaceutical company specializing in the development and potential commercialization of biosimilar pharmaceutical products. It is in the process of preclinical trials of five major biosimilar products in South Korea, including Interferon Beta 1b, .....See More See More

Auditor: DALE MATHESON CARR-HILTON LABONTE LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2017 2016 2015 2014 2013 2020
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: